Harmankaya N - Search Results

1

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.

Genina N, Boetker JP, Colombo S, Harmankaya N, Rantanen J, Bohr A. Genina N, et al. Among authors: harmankaya n. J Control Release. 2017 Dec 28;268:40-48. doi: 10.1016/j.jconrel.2017.10.003. Epub 2017 Oct 6. J Control Release. 2017. PMID: 28993169

2

Molecular weight-dependent degradation and drug release of surface-eroding poly(ethylene carbonate).

Bohr A, Wang Y, Harmankaya N, Water JJ, Baldursdottír S, Almdal K, Beck-Broichsitter M. Bohr A, et al. Among authors: harmankaya n. Eur J Pharm Biopharm. 2017 Jun;115:140-148. doi: 10.1016/j.ejpb.2017.02.011. Epub 2017 Feb 24. Eur J Pharm Biopharm. 2017. PMID: 28238837

3

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.

Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y, Grohganz H, Rades T, Löbmann K. Bohr A, et al. Among authors: harmankaya n. Molecules. 2019 Jan 11;24(2):266. doi: 10.3390/molecules24020266. Molecules. 2019. PMID: 30642009 Free PMC article.

4

Exploring the potential for rosacea therapeutics of siRNA dispersion in topical emulsions.

Colombo S, Harmankaya N, Water JJ, Bohr A. Colombo S, et al. Among authors: harmankaya n. Exp Dermatol. 2019 Mar;28(3):261-269. doi: 10.1111/exd.13881. Epub 2019 Feb 12. Exp Dermatol. 2019. PMID: 30650201

5

Antioxidant-mediated control of degradation and drug release from surface-eroding poly(ethylene carbonate).

Bohr A, Nascimento TL, Harmankaya N, Antonino RSCMQ, Beck-Broichsitter M. Bohr A, et al. Among authors: harmankaya n. Acta Biomater. 2020 Sep 1;113:210-216. doi: 10.1016/j.actbio.2020.06.041. Epub 2020 Jul 2. Acta Biomater. 2020. PMID: 32623099

6

Raloxifene and alendronate containing thin mesoporous titanium oxide films improve implant fixation to bone.

Harmankaya N, Karlsson J, Palmquist A, Halvarsson M, Igawa K, Andersson M, Tengvall P. Harmankaya N, et al. Acta Biomater. 2013 Jun;9(6):7064-73. doi: 10.1016/j.actbio.2013.02.040. Epub 2013 Mar 5. Acta Biomater. 2013. PMID: 23467043

7

Healing of complement activating Ti implants compared with non-activating Ti in rat tibia.

Harmankaya N, Igawa K, Stenlund P, Palmquist A, Tengvall P. Harmankaya N, et al. Acta Biomater. 2012 Sep;8(9):3532-40. doi: 10.1016/j.actbio.2012.05.017. Epub 2012 May 22. Acta Biomater. 2012. PMID: 22633969

8

Ex vivo alendronate localization at the mesoporous titania implant/bone interface.

Karlsson J, Harmankaya N, Allard S, Palmquist A, Halvarsson M, Tengvall P, Andersson M. Karlsson J, et al. Among authors: harmankaya n. J Mater Sci Mater Med. 2015 Jan;26(1):5337. doi: 10.1007/s10856-014-5337-7. Epub 2015 Jan 11. J Mater Sci Mater Med. 2015. PMID: 25577217

9

Stem cell homing using local delivery of plerixafor and stromal derived growth factor-1alpha for improved bone regeneration around Ti-implants.

Karlsson J, Harmankaya N, Palmquist A, Atefyekta S, Omar O, Tengvall P, Andersson M. Karlsson J, et al. Among authors: harmankaya n. J Biomed Mater Res A. 2016 Oct;104(10):2466-75. doi: 10.1002/jbm.a.35786. Epub 2016 Jun 6. J Biomed Mater Res A. 2016. PMID: 27213764

10

The effect of heat- or ultra violet ozone-treatment of titanium on complement deposition from human blood plasma.

Linderbäck P, Harmankaya N, Askendal A, Areva S, Lausmaa J, Tengvall P. Linderbäck P, et al. Among authors: harmankaya n. Biomaterials. 2010 Jun;31(18):4795-801. doi: 10.1016/j.biomaterials.2010.02.060. Epub 2010 Apr 3. Biomaterials. 2010. PMID: 20363497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters